This invention relates to a method for identifying biological agents using high temperature superconductor enhanced nuclear quadrupole resonance. The targeted biological agents are attached to functionalized nanoparticles and the quadrupole nuclei in these nanoparticles are detected by the nuclear quadrupole resonance detection system.